Navigation Links
Gender Issues in Clinical Trials, New Life Science Webinar Hosted by Xtalks and IRB Services
Date:9/30/2013

Toronto, Canada (PRWEB) September 30, 2013

Meeting subject recruitment targets in clinical trials in this “hurry-up” era of global competitive clinical trial enrolment is already a major challenge for sponsors and researchers. At the same time, fuller understanding of the genetic, metabolic and physiologic differences between genders is crucial to the development of safer and more effective drugs and medical devices for both men and women. These two imperatives are not mutually exclusive.

FDA, ICH, and most recently Health Canada, have all issued guidance to encourage, if not actually require, sponsors to include more women in clinical trials. IRBs are both ethically and legally bound to ensure that subject selection is equitable, and that both men and women are represented.

Yet, despite the ethical necessity and regulatory encouragement, most available evidence shows there still are significant gender inequalities in clinical trial participation – women continue to be underrepresented, and equitable participation of both sexes remains an elusive yet necessary goal.

Dr. Gordon DuVal will briefly discuss the principle of distributive justice, the ethical requirements for equitable subject selection, specifically as applied to women in research. Dr. Agnes Klein will discuss the issues from Health Canada’s perspective as the regulatory agency with the most recent and perhaps most progressive guidance in the world on the inclusion of women in clinical trials. CISCRP’s Mr. Zach Hallinan will offer specific insights into the practical barriers to overcome, and some strategies that can be successfully employed by sponsors and sites to encourage better engagement and improved recruitment and retention of women in clinical trials, a legal, moral and pragmatic imperative.

Mr. Jack Corman, President and Founder of IRB Services (Institutional Review Board Services), will join the panel for a live Q&A with
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Midwest Specialty Distribution Plant Expanding as Companies Focus on Sales and Distribution Issues
2. The FSH Society Issues Research Grant for Developing New Facioscapulohumeral Dystrophy Muscular Measurement Tool
3. Damaged Tissues and Organs Could be Repaired With New Scaffolding Technique
4. Vaginal Ring Provides “Radically New” Drug Delivery Platform for Health Issues, Including Infertility
5. Signal-Health Develops Easy Checklist to Identify Possible Sweating Issues in Horses
6. The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA
7. First patent issues on TAL effector technology
8. Crystal Research Associates, LLC Issues Quarterly Update on MetaStat, Inc.
9. UCB and Emory partner to address pressing public health issues for people living with epilepsy
10. EAS Consulting Group, Experts in Quality Regulatory Services Related to FDA Issues, Announces Upcoming Dietary Supplement Seminars in Salt Lake City
11. New MRI method fingerprints tissues and diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2015)... (PRWEB) April 23, 2015 Athena San ... development of executive women in San Diego’s technology and ... 17th Annual Pinnacle Awards at their Gala on April ... Hotel. Register now at http://athenasd.org/events/ , The ... the Athena San Diego vision of fostering networking, risk ...
(Date:4/23/2015)... ORLANDO, Fla. , April 23, 2015 ... . releases his book "Age Healthier Live Happier - ... kick off the Age Management Medicine Group Conference at ... - 26, 2015. ",Age Healthier Live Happier, ... looking to avoid over-medication and searching for a higher ...
(Date:4/23/2015)... WuXi PharmaTech (Cayman) Inc. (NYSE: WX ... company serving the pharmaceutical, biotechnology and medical device industries, ... the United States , today announced ... quarter of 2015 after the New York Stock Exchange ... Thursday morning, May 14, 2015 Shanghai time). The earnings ...
(Date:4/23/2015)... , April 23, 2015  Veracyte, Inc. (NASDAQ: VCYT ... definitive agreement to sell approximately $40 million of its ... the investors will purchase an aggregate of 4,907,975 shares ... per share, the closing stock price on April 22, ... existing investors, including Broadfin Capital, Camber Capital, Deerfield, Longwood ...
Breaking Biology Technology:Athena Pinnacle Awards to Honor Executives, Corporations and Educators Working to Promote Women Leaders 2Release and Book Signing of BioTE Medical President Gary Donovitz M.D. 'Age Healthier Live Happier' at Age Management Medicine Group (AMMG) Conference 2Release and Book Signing of BioTE Medical President Gary Donovitz M.D. 'Age Healthier Live Happier' at Age Management Medicine Group (AMMG) Conference 3WuXi PharmaTech Schedules First-Quarter 2015 Earnings Release 2WuXi PharmaTech Schedules First-Quarter 2015 Earnings Release 3Veracyte, Inc. Announces $40 Million Private Placement 2Veracyte, Inc. Announces $40 Million Private Placement 3Veracyte, Inc. Announces $40 Million Private Placement 4
... Ltd,(SWX: ARPN) announced today the results of a ... iclaprim and warfarin.,Warfarin is widely used for the ... to be well-controlled.The drug-drug interaction study,comprised 24 healthy ... with and without pre- and co-administration of iclaprim ...
... Acclaimed stem cell researcher Shinya Yamanaka, MD, PhD, ... have successfully reprogrammed human adult cells to function like ... much of the controversy and restrictions regarding generation of ... in the journal Cell, should accelerate the pace of ...
... - Appointment of Company Officers ... ... - 1 Stock ... Meeting held on,November 7 2007, Monica R. Brettler, Tush P. Nikollaj, Carl H. Rosner and,Arthur Roth were elected to ...
Cached Biology Technology:Positive Outcome of Drug-Drug Interaction Trial With Intravenous Iclaprim 2Positive Outcome of Drug-Drug Interaction Trial With Intravenous Iclaprim 3Shinya Yamanaka reprograms human adult cells 2CardioMag Announces Results of 2006 Annual Shareholders Meeting and Board Meeting 2
(Date:4/10/2015)... , April 10, 2015 Research ... of the "Security Competitive Profiles - NEC" ... , NEC will continue to supply a ... the market, with a company focus on the development ... Winning opportunities in the Asia-Pacific ...
(Date:4/8/2015)... , April 8, 2015  Infinisource, a leading ... services, and Morpho, a leading supplier of biometric ... produce the market,s most advanced biometrically-enabled time clock, ... NXG time clock is setting a bold, new ... data for the small and mid-size employer. When ...
(Date:4/2/2015)... Germany , April 2, 2015 ... fingerprint tests DERMALOG by far outperforms the strongest ... always maintaining high accuracy, the system is capable ... Hence, the speed proves up to be ten ... faster than its runner-up performance.      ...
Breaking Biology News(10 mins):NEC Security Competitive Profile 2015 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3
... do undergraduate students gain valuable hands-on experience by participating ... contributions, examples of which are highlighted in the current ... a peer-reviewed journal published by Mary Ann Liebert, Inc. ... This special issue features a collection of papers ...
... Scientists at The Scripps Research Institute have designed a new ... drugs targeting a human metabolic enzyme believed to stimulate the ... new test, which the scientists call a simple assay, will ... for those that have potential to block the action of ...
... LA JOLLA, CA September 16, 2010 For Immediate ... been awarded a four-year, $5.1 million grant as part of ... development of the next generation of DNA sequencing technologies, which ... sequence a person,s DNA. With the new grant, ...
Cached Biology News:Undergraduate research highlighted in DNA and Cell Biology Journal 2Scripps scientists develop test providing new pathway for identifying obesity, diabetes drugs 2Scripps scientists develop test providing new pathway for identifying obesity, diabetes drugs 3Scripps research team wins $5.1 million to develop DNA sequencing technology 2
... The lyophilization stabilizer is designed to ... and for long-term storage. There ... ingredients. It is a convenient ... 7.2, and is superior to other ...
... The CERTOMAT IS, a true benchtop incubator-shaker, has ... Having a footprint of 540 x 680 ... large incubation chamber (370 x 505 x 510mm). ... the CERTOMAT IS is ideal for shaking applications ...
... TC-3000 is one of the smallest thermal cyclers ... choice of either the 0.5ml (20 samples) or ... , Fast heating and cooling rate of ... and high performance Fast track programming with ...
... StabilZyme HRP Conjugate Stabilizer is an aqueous ... and other non-toxic stabilizing chemicals in a ... 6.7. This product contains a ... 20 ppm Proclin 300 (Rohm and Haas ...
Biology Products: